FDA-Drug2026-01-21Class III
Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel; Dist. by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC# 51672-4081-4
SUN PHARMACEUTICAL INDUSTRIES INC
Hazard
Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.
Sold states
Nationwide in the USA.
Manufactured in
2 Independence Way, Princeton, NJ, United States
Products
Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel; Dist. by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC# 51672-4081-4
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0257-2026Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief